Onyx Pharmaceuticals to Present at Upcoming Investor Conferences
June 06 2013 - 3:00PM
Marketwired
Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced that it
will present at two upcoming investor conferences in June and July.
Goldman Sachs 34th
Annual Global Healthcare Conference Onyx will
present at the Goldman Sachs 34th Annual Global Healthcare
Conference on Wednesday, June 12, 2013 at 10:00 a.m. Pacific Time
(1:00 p.m. Eastern Time).
8th Annual JMP Securities Healthcare Conference Onyx will
present at the 8th Annual JMP Securities Healthcare Conference on
Wednesday, July 10, 2013 at 10:00 a.m. Eastern Time (7:00 a.m.
Pacific Time).
To access the live webcasts, log onto the company's website at:
http://www.onyx.com/investors/event-calendar
It is recommended that listeners log on 15 minutes early in
order to register and download any necessary software. For those
unable to participate during the live webcast, a recorded replay of
the presentation will be available within 24 hours of the
completion of the presentation through the following dates:
- Goldman Sachs 34th Annual Global Healthcare Conference - June
26, 2013
- 8th Annual Securities Healthcare Conference - July 24,
2013
About Onyx Pharmaceuticals, Inc. Based in
South San Francisco, California, Onyx Pharmaceuticals, Inc. is a
global biopharmaceutical company engaged in the development and
commercialization of innovative therapies for improving the lives
of people with cancer. The company is focused on developing novel
medicines that target key molecular pathways. For more information
about Onyx, visit the company's website at www.onyx.com. Onyx
Pharmaceuticals is on Twitter. Sign up to follow our Twitter feed
@OnyxPharm at http://twitter.com/OnyxPharm.
Contact: Nicole Keith 650-266-2123
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Onyx Pharmaceuticals, Inc. (MM) (NASDAQ): 0 recent articles
More Onyx Pharmaceuticals, Inc. News Articles